High-dose DICEP chemotherapy versus observation in metastatic breast cancer patients with monotopic disease responding to induction chemotherapy with paclitaxel plus epirubicin. Final results of a phase III GEICAM trial. - Martín, Miguel; García-Puche, José; Casado, Antonio; Talavera, María; Menéndez, María; Alba, Emilio; Pelegrí, Amadeu; Balil, Ana; Rodríguez-Lescure, Álvaro; Casinello, Javier; Lozano, Ana; Pérez-Carrión, Ramón; et al. (Clinical & translational oncology: official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2003)